D. Baird William's most recent trade in 2seventy bio Inc was a trade of 1,002,825 Common Stock done . Disclosure was reported to the exchange on May 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 1,002,825 | 118,209 | - | - | Common Stock | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 182,000 | 0 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 176,000 | 0 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | 13 May 2025 | 118,209 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 17 Mar 2025 | 5,092 | 1,121,034 | - | 4.9 | 25,180 | Common Stock |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 264,000 | 1,126,126 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 176,000 | 176,000 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 03 Jan 2025 | 31,718 | 862,889 | - | 2.9 | 93,121 | Common Stock |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.78 per share. | 03 Jan 2025 | 763 | 862,126 | - | 2.8 | 2,120 | Common Stock |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 586,022 | 894,607 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 112,500 | 112,500 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 56,250 | 308,585 | - | 0 | Common Stock | |
| 2seventy bio Inc | D. Baird William | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 182,000 | 182,000 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | D. Baird William | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 91,000 | 252,335 | - | 0 | Common Stock | |
| 2seventy bio Inc | William Baird D. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 05 Jan 2024 | 1,380 | 161,335 | - | 3.8 | 5,180 | Common Stock |
| 2seventy bio Inc | William Baird D. | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 03 Jan 2024 | 33,651 | 162,715 | - | 3.9 | 130,179 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.49 per share. | 22 Aug 2023 | 7,031 | 196,366 | - | 5.5 | 38,576 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 03 Aug 2023 | 6,906 | 203,397 | - | 6.1 | 42,304 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.86 per share. | 13 Feb 2023 | 637 | 210,303 | - | 12.9 | 8,192 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 107,143 | 210,940 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 25,000 | 103,797 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 11 Jan 2023 | 1,077 | 78,797 | - | 10.6 | 11,446 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.33 per share. | 09 Jan 2023 | 3,222 | 79,874 | - | 10.3 | 33,298 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.23 per share. | 05 Aug 2022 | 4,152 | 83,096 | - | 16.2 | 67,397 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.81 per share. | 15 Jul 2022 | 4,080 | 87,248 | - | 13.8 | 56,344 | Common Stock |
| Axcella Health Inc | William D. Baird | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 67,500 | 67,500 | - | - | Stock Option (Right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 33,750 | 91,328 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 17 Feb 2022 | 427 | 57,578 | - | 14.8 | 6,311 | Common Stock |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.91 per share. | 07 Jan 2022 | 896 | 58,005 | - | 23.9 | 21,421 | Common Stock |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 60,000 | 59,072 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 21,628 | 34,599 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 21,627 | 58,901 | - | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 20,000 | 19,690 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 19,690 | 19,690 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 16,098 | 16,098 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 8,049 | 12,971 | - | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 22,797 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 15,413 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 6,563 | 6,563 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 2,461 | 2,461 | - | 0 | Common Stock | |
| 2seventy bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 2,461 | 4,922 | - | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,585 | 69,114 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 33,584 | 102,698 (0%) | 0% | 0 | Common Stock | |
| Axcella Health Inc | William D. Baird | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 25,000 | - | - | Stock Options (Right to buy) | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 12,500 | 34,081 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,141 | 36,222 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 16 Feb 2021 | 693 | 35,529 (0%) | 0% | 28.2 | 19,516 | Common Stock |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.52 per share. | 12 Feb 2021 | 1,216 | 21,581 (0%) | 0% | 45.5 | 55,352 | Common Stock |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 06 Jan 2021 | 552 | 23,194 (0%) | 0% | 44.8 | 24,707 | Common Stock |
| Bluebird bio Inc | William D. Baird | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.46 per share. | 06 Jan 2021 | 397 | 22,797 (0%) | 0% | 45.5 | 18,049 | Common Stock |